3 High-Risk Biotechs That Could Pop or Drop in 2018 Post author:Sam Post published:February 4, 2018 Post category:BioPharma A look at three biotech companies that face make-or-break catalysts this year. Source: BioSpace You Might Also Like Zoning Changes Kills Sale of Bristol-Myers Squibb's Connecticut Campus February 20, 2017 6 Promising Biopharmas With Major Catalysts in 2018 January 28, 2018 3 Small Biotechs Big Drugmakers are Making Googly Eyes At January 28, 2018
